Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Department of Epigenetics, Van Andel Research Institute, Grand Rapids, MI, 49503, USA.
Reprod Sci. 2022 Nov;29(11):3266-3277. doi: 10.1007/s43032-022-00974-3. Epub 2022 May 26.
Endometriosis is a disease defined by the presence of abnormal endometrium at ectopic sites, causing pain and infertility in 10% of women. Mutations in the chromatin remodeling protein ARID1A (AT-rich interactive domain-containing protein 1A) have been identified in endometriosis, particularly in the more severe deep infiltrating endometriosis and ovarian endometrioma subtypes. ARID1A has been shown to regulate chromatin at binding sites of the Activator Protein 1 (AP-1) transcription factor, and AP-1 expression has been shown in multiple endometriosis models. Here, we describe a role for AP-1 subunit JUNB in promoting invasive phenotypes in endometriosis. Through a series of knockdown experiments in the 12Z endometriosis cell line, we show that JUNB expression in endometriosis promotes the expression of epithelial-to-mesenchymal transition genes co-regulated by ARID1A including transcription factors SNAI1 and SNAI2, cell adhesion molecules ICAM1 and VCAM1, and extracellular matrix remodelers LOX and LOXL2. In highly invasive ARID1A-deficient endometriotic cells, co-knockdown of JUNB is sufficient to suppress invasion. These results suggest that AP-1 plays an important role in the progression of invasive endometriosis, and that therapeutic inhibition of AP-1 could prevent the occurrence of deep infiltrating endometriosis.
子宫内膜异位症是一种以异位存在异常子宫内膜为特征的疾病,可导致 10%的女性出现疼痛和不孕。在子宫内膜异位症中,已经发现染色质重塑蛋白 ARID1A(富含 AT 的相互作用域蛋白 1A)的突变,特别是在更严重的深部浸润性子宫内膜异位症和卵巢子宫内膜异位囊肿亚型中。已经表明 ARID1A 可以调节结合激活蛋白 1(AP-1)转录因子的染色质,并且在多个子宫内膜异位症模型中已经显示出 AP-1 的表达。在这里,我们描述了 AP-1 亚基 JUNB 在促进子宫内膜异位症侵袭表型中的作用。通过在 12Z 子宫内膜异位症细胞系中进行一系列敲低实验,我们表明子宫内膜异位症中 JUNB 的表达促进了 ARID1A 共同调节的上皮-间充质转化基因的表达,包括转录因子 SNAI1 和 SNAI2、细胞黏附分子 ICAM1 和 VCAM1 以及细胞外基质重塑剂 LOX 和 LOXL2。在高度侵袭性的 ARID1A 缺陷型子宫内膜异位症细胞中,JUNB 的共敲低足以抑制侵袭。这些结果表明,AP-1 在侵袭性子宫内膜异位症的进展中发挥重要作用,AP-1 的治疗性抑制可能预防深部浸润性子宫内膜异位症的发生。